PPT Slide
BELGIAN CAP - GUIDELINES Premises (1)
1. No demonstrated need for systematic coverage of atypicals in subgroups 1, 2 and 3 atypicals in subgroups 1, 2 and 3 should be covered only when suspected on clinical or epidemiological grounds
2. In Belgium, presently available macrolides, azalides and older quinolones offer inadequate coverage of S. pneumoniae